CLOs on the Move

Glenn Long and Associates

www.gl-asc.com

 
Glenn Long & Associates, Inc. is a Hillsborough, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Julie Hewett

Julie Hewett is a North Hollywood, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Carlinville Area Hospital Association, Inc

Carlinville Area Hospital Association, Inc is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Carlinville, IL. To find more information about Carlinville Area Hospital Association, Inc, please visit www.cahcare.com

Elcelyx Therapeutics

lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.

WELLTODO

Search wellness jobs online and find a career in health, fitness and wellbeing. Discover incredible companies hiring now, tips to get the job, and support from industry experts...

RainTree Oncology Services

As the nation’s leading community oncology alliance, RainTree Oncology Services assists our member practices in achieving better and more cost effective treatment of oncology patients while creating new streams of revenue for community oncology practices through. Creating a unique aggregated data compilation and analytic platform allowing RainTree members to develop and evaluate care pathways to improve patient care and outcomes while reducing costs to the health care system; and Developing commercial relationships accelerating innovative oncology treatments and payer arrangements while optimizing oncology patient care and advancing the science of oncology.